Ordenar

Buscar

01/04/2026 Promoting Well-Being and Workforce Inclusion Through Healthy Leisure: Evidence from a Community-Based Youth Intervention
Brugueras, S, Continente, X, Daban, F, March, S, García, I, Vázquez, N, Lopez, MJ. Promoting Well-Being and Workforce Inclusion Through Healthy Leisure: Evidence from a Community-Based Youth Intervention. Journal of Prevention. 2026; 47(2)DOI:10.1007/s10935-025-00889-0. PMID:41359211. IF:1.500(Q3/7D).
01/04/2026 Older adults and major cardiovascular events requiring emergency department consultation during the 1st wave of the COVID-19 pandemic: results from the EDEN-4 Study
Salmerón, PP, Jacob, J, Miró, O, Burillo-Putze, G, García-Lamberechts, EJ, Pérez, FJM, Aguiló, S, Fernández, C, Alquézar-Arbé, A, Olagüenaga, AM, Miguez, FJD, Sousa, M, Asensio, PR, Díaz, BP, Pizarro, TP, Gómez, MAD, Viola, NP, Hernández-Castells, L, Soler, AC, Sardina, VD, Serrano, JAS, Ezponda, P, Lorenzo, AM, Liarte, JVO, Fernández, RH, Aranda, AR, del Castillo, JG. Older adults and major cardiovascular events requiring emergency department consultation during the 1st wave of the COVID-19 pandemic: results from the EDEN-4 Study. EMERGENCIAS. 2026; 38(2)DOI:10.55633/s3me/027.2026. PMID:41880167. IF:6.300(Q1/1D).
01/04/2026 First-in-class SAM-competitive G9a inhibitor FLAV-27 as adisease-modifying therapy for Alzheimer disease
Bellver-Sanchis, A, Valle-Garcia, D, Barbaraci, C, Romero-Becerra, F, Singh, RK, Jarne-Ferrer, J, Vasilopoulou, F, Irisarri, A, Martínez-Fernández, C, Fafián-Labora, JA, Arufe, MC, Wüst, C, Castellanos, A, Soto, D, Casals, N, Fadó, R, Pocock, JM, Navarro, G, Val, C, Brea, J, Loza, MI, Lleó, A, Fortea, J, Alcolea, D, Perez-Bosque, A, Miró, L, Pérez, B, Rashid, S, Ali, M, Saqib, M, li Carbó, M, Guerrero, A, Vázquez, S, Choudhary, BS, Dai, SD, Escolano, C, Franco, R, Pallàs, M, Griñán-Ferré, C. First-in-class SAM-competitive G9a inhibitor FLAV-27 as adisease-modifying therapy for Alzheimer disease. MOLECULAR THERAPY. 2026; 34(4)DOI:10.1016/j.ymthe.2025.12.038. PMID:41445192. IF:12.000(Q1/1D).
01/04/2026 Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages
Perovnik, M, Simoncic, U, Jamsek, J, Kramberger, MG, Brumberg, J, Meyer, PT, Perani, D, Caminiti, SP, Brendel, M, Stockbauer, AC, Camacho, V, Alcolea, D, Vandenberghe, R, Van Laere, K, Ko, JH, Lee, CS, Pardini, M, Lombardo, L, Padovani, A, Pilotto, A, Ochoa-Figueroa, MA, Davidsson, A, Cháfer-Pericás, C, Alvarez-Sánchez, L, Garibotto, V, Lemstra, AW, Ferreira, D, Morbelli, SD, Tang, CC, Eidelberg, D, Trost, M. Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2026; 97(4)DOI:10.1136/jnnp-2025-336935. PMID:41344886. IF:7.500(Q1/1D).